The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

Here’s what to know about the twice-yearly preventative HIV shot - A twice-yearly drug called lenacapavir is now the ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

WGN’s Patrick Elwood and Lourdes Duarte have the latest on new medical information, including: More Coverage: WGN’s ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have ...

The U.S. Food and Drug Administration approved an HIV prevention medication that has been proven highly effective in clinical ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.